Navigation Links
Boost For Japanese Pharma Market as UBM Announces Rescheduled Japan Pharma and Bio Events
Date:4/25/2011

AMSTERDAM, April 25, 2011 /PRNewswire/ -- Leading events organiser UBM Live is today happy to announce that, following the postponement of its CPhI, ICSE, P-MEC and BioPh Japan events in Tokyo as a result of the recent earthquake in northern Japan, the events have now been rescheduled and will be held from 13-15 July 2011 at the Intex Osaka Exhibition Centre.  The Japanese business community is intent on picking itself up as quickly as possible from the effects of the disaster and there is a strong feeling of the need to get back to business as usual. UBM anticipates that the Osaka events will attract over 150 exhibitors and around 8,000 visitors.  

In addition to being Japan's second largest city, Osaka is the center of the Kansai area, one of the main regions in Japan for pharmaceutical R&D and manufacturing, with numerous Japanese and multinational pharmaceutical companies having their head office, factories and R&D centers located there, and in surrounding cities. The events are conveniently located for visitors from prefectures in the Kansai region such as Osaka, Hyogo, Kyoto, Tokushima and Shiga, as well as other key pharmaceutical manufacturing prefectures with easy access to Osaka such as Toyama, Shizuoka, Aichi, Gifu and Yamaguchi.

"Following our initial announcement regarding the unfortunate postponement of the events in Tokyo, we received many requests from exhibitors asking if there was some way that we could facilitate an opportunity for them to meet their clients in Japan this year," commented Annemieke Timmers, CPhI Brand Director. "We also received unanimous feedback from our Japanese customers and we recognize that it is precisely at times such as this that CPhI Japan, along with ICSE, P-MEC and BioPh Japan, could help contribute towards the stable supply of pharmaceutical products in what is the second largest pharma market after the United States."

"After careful consi
'/>"/>

SOURCE UBM Live
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmaceutical Medical Affairs Functions Get a Boost in Budget, Staffing
2. Inovio Pharmaceuticals, Transgene and ChronTech Pharma to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C
3. New Analysis Finds Antidepressants Boost Patient Adherence to Hepatitis C Treatment
4. InspireMD Boosts MGuard Production Capacity
5. PaedRegCliNet e.V.: A Boost for Safe Pediatric Medications
6. Prolong Pharmaceuticals Boosts Executive Team
7. ALS Research Gets a $4.1 Million Boost from CVS/pharmacy Fundraising Campaign
8. Electronic Recordkeeping Boosts Patient Safety, Saves DMC More Than $5 Million - For Second Straight Year
9. George Soros to Boost Civil Society Response in Flood Affected Areas of Pakistan
10. Study Seeks Volunteers to Measure Safety of Treatment Boost for Patients with Oropharyngeal Cancer
11. Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014 Reportlinker.com ... available in its catalogue: Acute Heart ... http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html Acute ... Summary GlobalData,s clinical trial report, ... 2014" provides data on the Acute Heart Failure ...
(Date:9/2/2014)... SANTA CLARA, Calif. , Sept. 2, 2014 /PRNewswire/ ... , is now offering a special promotion for Invisalign. ... instead of brackets and wires. It is often the ... who prefer the convenience and aesthetics of it. For ... $3,900, which is a significant savings from the usual ...
(Date:9/2/2014)... September 2, 2014 ... ESC-Kongress 2014 präsentierte GARFIELD-AF-Register bietet einen ... von schlaganfallgefährdeten Patienten in der klinischen ... Daten der nahezu 12.500 ... und unabhängigen Forschungsinitiative zur Untersuchung von ...
Breaking Medicine Technology:Acute Heart Failure Global Clinical Trials Review, H2, 2014 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 4Acute Heart Failure Global Clinical Trials Review, H2, 2014 5Acute Heart Failure Global Clinical Trials Review, H2, 2014 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 7Acute Heart Failure Global Clinical Trials Review, H2, 2014 8Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 2Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 3Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 4Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 5Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 6Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 7Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 8Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 9Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 10Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 11
... 15, 2011 Pharmaceutical companies are dramatically increasing ... meet the demands of a patient-empowered, data-driven, outcomes-focused ... alone, pharmaceutical company investment in smart phone apps, ... other programs increased 78%, as companies embrace a ...
... Unilife Corporation ("Unilife" or "Company") (Nasdaq: ... the three and six months ended December 31, 2010 (Fiscal ... Completed, on-schedule, the construction of a new ... staff now working out of the new facility ...
Cached Medicine Technology:Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 2Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 3Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 4Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 5Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 2Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 3Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 4Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 5Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 6Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 7
(Date:9/2/2014)... become an increasing concern to health officials both in ... Department of Health and Mental Hygiene, the number of ... the number of such deaths in 2000. Much of ... in nonmedical prescription opioid (PO) use among teens and ... youth who transitioned from POs to heroin. , ...
(Date:9/2/2014)... Two Kansas State University biochemists have discovered a family ... Staphylococcus aureus , a pathogenic bacterium that can ... , Brian Geisbrecht, professor of biochemistry and molecular biophysics, ... S. aureus , which is the cause of increasing ... journal Proceedings of the National Academy of Sciences ...
(Date:9/2/2014)... that a mother,s eating habits prior to pregnancy, during ... her offspring and their propensity for developing weight problems, ... this phenomenon were unclear. According to new research published ... FASEB Journal F , scientists using an animal model ... an offspring,s risk of future obesity. This link hinges ...
(Date:9/2/2014)... Many people believe that marijuana is not addictive, but ... people are able to obtain and consume cannabis legally ... are less likely to perceive it as addictive or ... General Hospital,s Center for Addiction Medicine, said in a ... use can have significant consequences, and we know that ...
(Date:9/2/2014)... HMP Communications Holdings , LLC, a leader ... the acquisition of Nutrition411.com , a vibrant news ... who integrate diet and nutrition into patient consultations. , ... , Late-breaking news related to nutrition and disease ... oncology, renal disease, wound care, and pediatrics , ...
Breaking Medicine News(10 mins):Health News:NYC teens and young adults who abuse prescription at high risk for overdose 2Health News:NYC teens and young adults who abuse prescription at high risk for overdose 3Health News:Biochemists find new treatment options for staph infections, inflammatory diseases 2Health News:How genes link a mother's diet to the risk of obesity in her offspring 2Health News:'Pot Addiction' May Be Real, Study Suggests 2Health News:HMP Communications Holdings, LLC, Acquires Nutrition411.com 2
... converts to Masimo SET pulse oximetry and leverages ... ... capabilities, IRVINE, Calif., Feb. 13 Masimo, the inventor,of Pulse ... of UCSF Medical Center,s,system-wide implementation of Masimo SET pulse oximetry and ...
... SEATTLE, Feb. 13 An intriguing new offering ... Climb to Fight,Breast Cancer(R) benefiting Fred Hutchinson Cancer Research ... international slate of peaks to,include two expeditions to central ... (17,343 feet). Both trips will be led by,professional guides ...
... Underwriters, Inc. (Darwin) (NYSE: DR ) ... Specialty Product Network Insurance,Services, Inc. (ASPN)., ... the announced arrangement, ASPN,s nationwide team of ... intended to spread the,word about Darwin,s unique ...
... been able to eradicate the virus from infected individuals who ... HIV in hideouts known as viral reservoirs. One important reservoir ... due to the large number of HIV target cells that ... largely contained in lymph nodes and patches of lymphocytes that ...
... TOWN, W.V., Feb. 13 ReBuilder Medical,Technologies, ... of the art,electronic devices for diabetic peripheral ... up 89% over last year, details,are available ... ., (Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO ), ...
... results need to be replicated in larger study, experts ... drug originally designed to combat cancer that is now ... arthritis and lupus might also work against a common ... in the Feb. 14 issue of the New ...
Cached Medicine News:Health News:The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology 2Health News:The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology 3Health News:The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology 4Health News:The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology 5Health News:Climb to Fight Breast Cancer Offers Peaks for Every Skill Level 2Health News:Darwin Enters into Marketing Partnership with Agency Specialty Product Network 2Health News:HIV persists in the gut despite long-term HIV therapy 2Health News:ReBuilder Medical Technologies, Inc. Announces 2007 Sales Nearly Doubled Sales in 2006 2Health News:Cancer Drug Works Against MS in Early Trial 2Health News:Cancer Drug Works Against MS in Early Trial 3
... DXC-990 camera is a 3 chip 1/2 inch color ... and a high s/n ratio. It offers picture contrast ... and knee control. The user can choose automatic exposure ... The Sony DXC-990 camera is a bayonet mount and ...
Sony DSR-20MD is the right choice If you need digital recording capability. It accepts both s-video and composite inputs....
... image management. Mediscan is an advanced ... derived from extensive experience with clinicians. ... organize, and distribute high quality images, ... effort. Can be connected to flexible ...
For continuous intracranial monitoring of pressure, oxygen and temperature of the brain...
Medicine Products: